Gateways to clinical trials -: January/February 2003

被引：0

作者：

Bayés, M ^{[1
]}

Rabasseda, X ^{[1
]}

Prous, JR ^{[1
]}

机构：

[1] Prous Sci SA, Barcelona 08080, Spain

来源：

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2003年 / 25卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies knowledge area of Prous Science Integrity, the drug discovery and development portal, http://integrity.prous.com. This issue focuses on the following selection of drugs: 81C6; Adefovir dipivoxil, Agalsidase alfa, AGM-1470, albumin interferon alfa, alefacept, alosetron hydrochloride, anakinra, anti-CTLA-4 Mab, aprepitant, aripiprazole, atazanavir,BAY-43-9006, BBR-3438, beta-L-Fd4C, bimatoprost, bortezomib, bosentanBR96-doxorubicin; Caspofungin acetate, ciclesonide, cilengitide, cilomilast, COL-1621, COL-3, CpG-7909, cyclosporine; DCVax-Brain, dexmethylphenidate hydrochloride, dexosome vaccine (melanoma), donepezil hydrochloride, drotrecogin alfa (activated), DTI-015, [99Tc]-DTPA-mannosyldextran, duloxetine hydrochloride; Emivirine, emtricitabine, entecavir, epothilone B, estradiol-MNP, etonogestrel, etonogestrel/ethinylestradiol, etoricoxib; Febuxostat, fondaparinux sodium, fosamprenavir calcium; Gefitinib, GVS-111; Heparinase 1, HspE7, human alpha-glucosidase, human insulin; Imatinib mesylate, INGN-241, interferon alfa BID hybrid, interferon alfa Biphasix, ISIS-14803; Lanicemine hydrochloride, 131I-lipiodol, liposome-encapsulated mitoxantrone, lixivaptan, lumiracoxib, lupus-AHP, LY-466700; Marimastat, MEN-10755, micafungin sodium; Nitronaproxen, NSC-683864 Omalizumab, oral insulin; Palonosetron hydrochloride, peginterferon alfa-2a, pimecrolimus, pralnacasan, pramlintide acetate, pregabalin, pyrazoloacridine; R-165335, ranolazine, risperidone, RPR-109881;, RSD-1235, Satraplatin, seocalcitol, sertindole, SMART anti-interferon gamma antibody, sulfasalazine; T-138067, TAK-013, tegaserod maleate, telithromycin, tenofovir disoproxil fumarate, teriparatide, tiotropium bromide, tipifarnib, TP-38; Valdecoxib, vatalanib succinate, voriconazole; ZD-9331. (C) 2003 Prous Science. All rights reserved.

引用

下载

页码：53 / 76

页数：24

共 50 条

[21] Gateways to Clinical Trials
Bayes, M
Rabasseda, X
Prous, JR
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2002, 24 (04): : 217 - 248
[22] Gateways to clinical trials
Bayés, M
Rabasseda, X
Prous, JR
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2004, 26 (10): : 801 - 827
[23] Gateways to clinical trials
Bayes, M
Rabasseda, X
Prous, JR
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2002, 24 (01): : 37 - 55
[24] Gateways to clinical trials
Bayés, M
Rabasseda, X
Prous, JR
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2004, 26 (05): : 357 - 391
[25] Gateways to clinical trials
Bayés, M
Rabasseda, X
Prous, JR
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2003, 25 (10): : 831 - 855
[26] Gateways to clinical trials
Bayés, M
Rabasseda, X
Prous, JR
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2005, 27 (02): : 145 - 159
[27] Gateways to Clinical Trials
Bayés, M
Rabasseda, X
Prous, JR
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2005, 27 (03): : 193 - 219
[28] Gateways to Clinical Trials
Bayés, M
Rabasseda, X
Prous, JR
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2004, 26 (04): : 295 - 318
[29] Gateways to clinical trials
Bayés, M
Rabasseda, X
Prous, JR
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2005, 27 (04): : 265 - 284
[30] Gateways to clinical trials
Bayés, M
Rabasseda, X
Prous, JR
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2002, 24 (08): : 525 - 551

← 1 2 3 4 5 →